Virginia House Bill HB336

Virginia 2026 Regular Session

• Introduced: 1/11/26
• Refer: 1/11/26
• Report Pass: 2/6/26

Caption

Fetal and Infant Mortality Review Team; established, penalty, report.

Impact

If enacted, HB336 would amend existing sections of the Code of Virginia, particularly focusing on health and social services records associated with fetal and infant health. By facilitating an organized review process, the bill may lead to enhanced public health policies and targeted interventions that address the root causes of fetal and infant mortality. Furthermore, it emphasizes the importance of data confidentiality while still prioritizing impactful health improvements. This is expected to bring long-term benefits to maternal and child health norms within the state.

Summary

House Bill 336 aims to establish the Fetal and Infant Health Data and Quality Improvement Review Team in Virginia, with the purpose of reviewing data related to fetal and infant mortality. This initiative is intended to improve health outcomes for infants and pregnant individuals by evaluating critical health information and identifying areas requiring attention. The bill proposes specific duties for the review team, including analyzing health data to improve the quality of care and ultimately decrease mortality rates among this vulnerable population.

Sentiment

The general sentiment around HB336 seems to trend positively among health professionals and community advocates who recognize the importance of addressing fetal and infant mortality. Proponents argue that systematic data analysis and an established review team will lead to improved health outcomes. Critics, however, may raise concerns regarding implementation costs, data privacy, and the potential bureaucratic complexity surrounding a new state entity. Overall, the discussion highlights a collective commitment to enhancing healthcare for at-risk populations.

Contention

Notable points of contention include discussions about potential barriers to data sharing and the need for stringent confidentiality protocols to protect sensitive health information. Some legislators might express concerns regarding the bill's scope and whether it adequately considers the diverse circumstances surrounding infant mortality. The establishment of such a review team might also raise questions about its integration within existing health frameworks and the funding necessary to support its operations and objectives.